ROME, April 5, 2013 /PRNewswire/ --
Serono Symposia International Foundation (SSIF) organizes the second live educational meeting entitled "Adherence to treatment in chronic disease: focusing on diabetes, growth disorders and multiple sclerosis" in Rome on April 5th-6th 2013. The major international experts on Endocrinology and on Neurology will discuss the main aspects and recent achievements in managing the adherence to treatment in these three chronic conditions.
(Photo: http://photos.prnewswire.com/prnh/20120501/529205 )
Adherence to treatment is a critical factor associated with the efficacy of managing chronic disease: its rate being only about 50% in developed countries and resulting in poor healthcare outcomes, in terms of higher morbidity and mortality.
Diabetes and growth disorders in the field of endocrinology as well as multiple sclerosis in neurology are major chronic conditions deeply affected by a low rate of adherence to treatment.
"Children receiving growth hormone therapy have the best growth results when they have good adherence, but adherence rates are often low. - said Doctor Marco Cappa, Director of Endocrinology Unit of the Ospedale Pediatrico Bambino Gesù, Rome, Italy - Most barriers to good adherence can be overcome by maintaining a good relationship with the children and their families."
The problem is even greater in diabetes, either type 1 or 2. In this world widespread disease, not taking the prescribed treatment properly is considered the main factor behind complications and related mortality. A multidisciplinary approach could help to improve adherence to treatment in this disease.
In the field of neurology, Multiple sclerosis (MS) is a progressive chronic disease requiring specific treatment.
"Many factors - declared Professor Giancarlo Comi, Director of the Department of Experimental Neurology within the Neurology Institute of Vita-Salute San Raffaele University, Milan, Italy - contribute to poor adherence in patients with MS. In order to maximise benefits and minimize risks, several strategies can be employed to promote adherence: patient education and information are crucial for treatment adherence and should be part of an open and honest dialogue between the clinician and the patient."
"This initiative is continuing our tradition of supporting patient care through dedicated medical education for healthcare professionals. - says Rachel Clark, SSIF Chief Executive Officer - That's why also psychologists, nurses and general practitioners are going to participate to the Rome meeting that will provide all learners with best solutions for optimizing patient care in their daily clinical practice."
Alessia Addessi, Alessia.Addessi@seronosymposia.org, +39(06)420413-591.
Share this article